ArticleBiomolecules2023

Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases.

Michał Załuski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.